BioNTech SE
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $260,800 | $182,800 | $1,190,000 | $1,244,800 |
Gross Profit | 184,400 | 99,000 | 946,500 | 1,065,900 |
EBITDA | -348,300 | -368,700 | 278,300 | 211,100 |
EBIT | -399,300 | -411,500 | 158,500 | 166,700 |
Net Income | -386,600 | -415,800 | 259,500 | 195,455 |
Net Change In Cash | 260,800 | 182,800 | 1,190,000 | 1,244,800 |
Free Cash Flow | 116,300 | -1,398,800 | -554,400 | -699,410 |
Cash | 10,269,500 | 10,184,900 | 9,761,900 | 9,624,600 |
Basic Shares | 241,625 | 240,346 | 240,277 | 244,567 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,751,100 | $3,819,000 | $17,310,600 | $18,976,700 |
Gross Profit | 2,209,800 | 3,219,200 | 12,778,600 | 15,116,000 |
EBITDA | -367,100 | 1,087,600 | 12,857,778 | 15,730,420 |
EBIT | -665,100 | 904,200 | 12,736,699 | 15,652,220 |
Net Income | -665,300 | 930,300 | 9,434,400 | 10,292,500 |
Net Change In Cash | 2,751,100 | 3,819,000 | 17,310,600 | 18,976,700 |
Free Cash Flow | -244,600 | 4,665,900 | 13,214,100 | 735,700 |
Cash | 9,761,900 | 11,663,700 | 13,875,100 | 1,692,700 |
Basic Shares | 240,400 | 242,700 | 249,800 | 259,700 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.60 |
2025-03-31 | -$1.82 |
2024-12-31 | $1.08 |
